Corvus Pharmaceuticals Initiates Clinical Trial of Novel Immunotherapy for Patients with COVID-19 Read more
Turning Point Therapeutics and Zai Lab Announce Exclusive License Agreement for Repotrectinib in Greater China Read more
EIB and EC provide CureVac with a €75 million financing for vaccine development and expansion of manufacturing Read more
GSK and Medicago announce collaboration to develop a novel adjuvanted COVID-19 candidate vaccine Read more
Regeneron Announces Start of REGN-COV2 Phase 3 COVID-19 Prevention Trial in Collaboration with NIAID Read more
Sunovion Announces Topline Results from Global Phase 2 Study of SEP-4199 in Patients with Bipolar I Depression Read more